Skip to main content

Noctiva News

FDA Medwatch Alert: Ferring US Issues Voluntary Nationwide Recall of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 mg/mL Due to Superpotency

August 05, 2020 – Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray...

FDA Approves Noctiva (desmopressin acetate) Nasal Spray for Nocturia in Adults

March 3, 2017 – The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Noctiva patient information at Drugs.com